SIRA: Prostate Cancer
Cancer
|
-
Currently 0.00/5
- 1
- 2
- 3
- 4
- 5
Rating: 0.0 out of 0 votes
Comments (0)
|
You need to have the
Flash Player installed and
a browser with JavaScript support.
Description
National recognized expert, Christopher Kane, MD, Urology Chief, UCSD Medical Center, reviews Prostate Cancer epidemiology and risk assessment information such as serum PSA, clinical stage, Gleason grade and biopsy information. He also reviews the stage and risk migration that has occurred throughout the PSA era. Finally, Dr. Kane reviewed robotic radical prostatectomy and how this exciting new technology is applied to prostate cancer surgery. Series: SIRA (Sam and Rose Stein Institute for Research on Aging) [5/2008] [Health and Medicine] [Show ID: 14199]
|
Tags
|
Sign in or sign up to post comments.